Clinical Trial Update: INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus

View source ↗

Summary

This clinical trial update reports a completed retrospective study of temsirolimus in renal cell carcinoma and mantle cell lymphoma. Results were posted in 2016…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma
• Renal Cell Carcinoma

Drugs mentioned

• Torisel (Temsirolimus)

Snippet

Sponsor: Pfizer | Conditions: Carcinoma, Renal Cell, Lymphoma, Mantle-Cell | Status: COMPLETED | Results posted: 2016-04-27